Trial Details
Not recruitingBasic Information
| Clinical ID | c4242 |
|---|---|
| Identifier | NCT00799266 |
| Trial Title | A Multicenter, Randomized, Double-blind, Placebo Controlled Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly Compared to Placebo in Osteoporotic Children Treated With Glucocorticoids. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Osteoporosis |
| Interventions | Drug: Zoledronic acid;Drug: Placebo |
Participant Information
| Sponsor | Novartis Pharmaceuticals |
|---|---|
| City | NULL |
| Country/Region | Australia;Canada;Hungary;Russia;South Africa;United Kingdom;Belgium;Finland;Germany;Italy;New Zealand;Poland;Romania;Turkey;United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, TEENAGER |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |